Agond Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 31.55%
- Profit Growth -19.17%
- Ebitda -6.05%
- Net Worth 23.19%
- Total Assets 9.13%
About Agond Lifesciences
Agond Lifesciences Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 November 2013 and has a history of 11 years and three months. Its registered office is in Karnal, Haryana, India.
The Corporate was formerly known as Unexo Products And Traders Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ravinder Rana and Sunita Rana serve as directors at the Company.
Company Details
- Location
Karnal, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999HR2013PTC050897
- Company No.
050897
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Nov 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Agond Lifesciences Private Limited offer?
Agond Lifesciences Private Limited offers a wide range of products and services, including Sexual Wellness Products, Fertility Enhancer, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Nutraceuticals & Dietary Supplements, Vitamin & Multivitamin Injections, Mineral Supplement, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant, Animal Medicines & Health Care.
Who are the key members and board of directors at Agond Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravinder Rana  | Director | 12-Nov-2013 | Current |
| Sunita Rana | Director | 16-Apr-2018 | Current |
Financial Performance of Agond Lifesciences.
Agond Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.55% increase. The company also saw a substantial fall in profitability, with a 19.17% decrease in profit. The company's net worth Soared by an impressive increase of 23.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agond Lifesciences?
In 2023, Agond Lifesciences had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nowry Lifesciences LlpRavinder Rana is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Agond Lifesciences?
Unlock and access historical data on people associated with Agond Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agond Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agond Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
